Economy
Abu Dhabi Billionaire Considers IPO of Pharmaceuticals Business

(Bloomberg) –Abu Dhabi billionaire Bavaguthu Raghuram Shetty, the founder of two London-listed companies, is considering selling shares in his pharmaceuticals business.
“It makes sense to take it down this path where an IPO as an option is a good thing,” said Binay Shetty, chief executive officer of BRS Ventures. Work on the potential share sale in Neopharma is at an initial stage, he said.
Shetty said the business could be listed in the next three years but that there was no decision on whether to return to London again. “We want to work on this for the next six months internally.”
Shetty’s father founded London-traded NMC Health Plc and Finablr Plc, the payments processor that went public in May. Neopharma currently operates in about 50 markets, including Middle East, Africa and Asia.
-
Banking & Finance1 month ago
Oman Arab Bank Announces Increase of Authorised Capital to RO500mn and Paid‑In Capital Boost of RO50mn
-
Bahrain1 month ago
SPIEF 2025 focused on global and regional economic processes, market transformation, new tech, investment climate, financial policy and people
-
Banking & Finance1 month ago
National Finance Reinforces Position as Partner for Growth, Offers a Comprehensive Product Suite to Support Customer Ambitions
-
OER Magazines1 month ago
OER, June 25
-
Energy1 month ago
Russian Energy Week from October 15-17, 2025 offers alternative formats of cooperation
-
Banking & Finance2 months ago
The Future of the International Financial System to be discussed at SPIEF 2025
-
Retail2 months ago
All services are moving toward personalisation says Tatyana Kim, Founder of Wildberries and Head of RWB
-
Alamaliktistaad Magazines1 month ago
Al-Iktisaad, June 25